Patents by Inventor Liam HALLADA

Liam HALLADA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteasome inhibitors
    Patent number: 11396497
    Abstract: The disclosure provides proteasome inhibitors that can be used to halt cell division of rapidly dividing cells by preventing the degradation of cell cycle-regulating proteins, such as cyclins, cyclin-dependent kinase inhibitors, and p53. The proteasome inhibitor compounds can be used to inhibit the proliferation of cancer cells.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: July 26, 2022
    Assignee: NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION
    Inventors: Rodolfo Tello-Aburto, Snezna Rogelj, Liam Hallada, Doleshwar Niroula
  • PROTEASOME INHIBITORS
    Publication number: 20210363119
    Abstract: The disclosure provides proteasome inhibitors that can be used to halt cell division of rapidly dividing cells by preventing the degradation of cell cycle-regulating proteins, such as cyclins, cyclin-dependent kinase inhibitors, and p53. The proteasome inhibitor compounds can be used to inhibit the proliferation of cancer cells.
    Type: Application
    Filed: May 2, 2019
    Publication date: November 25, 2021
    Inventors: Rodolfo TELLO-ABURTO, Snezna ROGELJ, Liam HALLADA, Doleshwar NIROULA